Cargando…

Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization

The COVID-19 pandemic continues to wreak havoc as worldwide SARS-CoV-2 infection, hospitalization, and death rates climb unabated. Effective vaccines remain the most promising approach to counter SARS-CoV-2. Yet, while promising results are emerging from COVID-19 vaccine trials, the need for multipl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiba, Shiho, Frey, Steven J., Halfmann, Peter J., Kuroda, Makoto, Maemura, Tadashi, Yang, Jie E., Wright, Elizabeth R., Kawaoka, Yoshihiro, Kane, Ravi S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134492/ https://www.ncbi.nlm.nih.gov/pubmed/34011948 http://dx.doi.org/10.1038/s42003-021-02128-8

Ejemplares similares

Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses
por: Halfmann, Peter J., et al.
Publicado: (2022)

Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
por: Halfmann, Peter J., et al.
Publicado: (2021)

Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters
por: Halfmann, Peter J., et al.
Publicado: (2022)

Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle Vaccine
por: Halfmann, Peter J., et al.
Publicado: (2023)

Protective Immunity and Persistent Lung Sequelae in Domestic Cats after SARS-CoV-2 Infection
por: Chiba, Shiho, et al.
Publicado: (2021)

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
por: Chiba, Shiho, et al.
Publicado: (2022)

Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages
por: Maemura, Tadashi, et al.
Publicado: (2021)

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021)

Pulmonary lesions induced by SARS-CoV-2 infection in domestic cats
por: Patania, Olivia M., et al.
Publicado: (2021)

Transmission and re-infection of Omicron variant XBB.1.5 in hamsters
por: Halfmann, Peter J., et al.
Publicado: (2023)

Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model
por: Halfmann, Peter J., et al.
Publicado: (2022)

HER2-mediated enhancement of Ebola virus entry
por: Kuroda, Makoto, et al.
Publicado: (2020)

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
por: Imai, Masaki, et al.
Publicado: (2020)

Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck
por: Braun, Katarina M., et al.
Publicado: (2021)

Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck
por: Braun, Katarina M., et al.
Publicado: (2021)

Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters
por: Boon, Adrianus C. M., et al.
Publicado: (2022)

Characterization of highly pathogenic clade 2.3.4.4b H5N1 mink influenza viruses
por: Maemura, Tadashi, et al.
Publicado: (2023)

Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
por: McMahan, Katherine, et al.
Publicado: (2022)

Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters
por: Takamatsu, Yuki, et al.
Publicado: (2022)

High Levels of miR-483-3p Are Present in Serum Exosomes Upon Infection of Mice With Highly Pathogenic Avian Influenza Virus
por: Maemura, Tadashi, et al.
Publicado: (2020)

Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study
por: Halfmann, Peter J., et al.
Publicado: (2019)

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
por: Sakai-Tagawa, Yuko, et al.
Publicado: (2021)

Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron
por: Chong, Zhenlu, et al.
Publicado: (2022)

Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
por: Changrob, Siriruk, et al.
Publicado: (2023)

Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction
por: Westmark, Cara J., et al.
Publicado: (2020)

Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes
por: Chiba, Shiho, et al.
Publicado: (2023)

Influenza Viruses Suitable for Studies in Syrian Hamsters
por: Fan, Shufang, et al.
Publicado: (2022)

Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron
por: Chong, Zhenlu, et al.
Publicado: (2022)

Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2
por: Ohtsuka, Junpei, et al.
Publicado: (2021)

The Cellular DExD/H-Box RNA Helicase UAP56 Co-localizes With the Influenza A Virus NS1 Protein
por: Chiba, Shiho, et al.
Publicado: (2018)

Synthesis of multivalent polymer–aptamer conjugates with enhanced inhibitory potency
por: Martin, Jacob T, et al.
Publicado: (2018)

Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures
por: Muramoto, Yukiko, et al.
Publicado: (2023)

A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs
por: Pattinson, David, et al.
Publicado: (2022)

Imaging the polymerization of multivalent nanoparticles in solution
por: Kim, Juyeong, et al.
Publicado: (2017)

Identification of interferon-stimulated genes that attenuate Ebola virus infection
por: Kuroda, Makoto, et al.
Publicado: (2020)

SARS-CoV-2 Transmission from Virus-Infected Dead Hamsters
por: Iwatsuki-Horimoto, Kiyoko, et al.
Publicado: (2023)

A multivalent Plasmodium falciparum circumsporozoite protein‐based nanoparticle malaria vaccine elicits a robust and durable antibody response against the junctional epitope and the major repeats
por: Pendyala, Geetanjali, et al.
Publicado: (2023)

SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo
por: Hou, Yixuan J., et al.
Publicado: (2020)

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
por: Halfmann, Peter J., et al.
Publicado: (2022)

Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus
por: Hatta, Masato, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cvv6fv1b82idc53jvv6260apo2